Mumps IgM - RRPL
Discipline
Microbiology
Overview
Description
Mumps is a viral illness characterized by painful swollen salivary glands (parotitis), fever, headache, muscle aches, weakness, and fatigue.
- The presence of mumps-specific IgM indicates acute or recent mumps infection or recent mumps vaccination.
Ordering recommendations
Measles IgM may be ordered for patients exhibiting Mumps symptoms.
- NOTE: IgM should only be requested on symptomatic patients. If acute Mumps infection is suspected, a buccal swab or urine should also be submitted for NAAT (PCR) testing (see Mumps NAAT compendium entry).
Specimen Information
Specimen types accepted
- Serum
Specimen collection container
- Serum separator tubes (SST; Tiger top or Gold top)
Collection procedure
- Serum (SST): Collect blood in serum separator vacutainer (SST). Centrifuge. Aliquot.
Required volume
- 1mL (minimum)
Transport and stability
- Serum may be shipped at ambient temperature.
Performance
Methodology
- Qualitative chemiluminescence immunoassay from DiaSorin (Positive/Indeterminate/Negative)
- NOTE: Results should be interpreted in conjunction with clinical symptoms, exposure, and vaccination history
Days/times performed
- All specimens will be tested at RRPL.
Maximum laboratory time
Turn-around-time of 3 days from receipt in lab.
Positive Mumps IgM results are reported to a Medical Health Officer.
NOTE: Specimens positive for Mumps IgM will automatically receive Mumps IgG testing.
Specimen retention time
- Specimens retained for 10 days after testing.
Last Updated: October 23, 2025